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Abstract
Background: Recent linkage between primary and secondary care data has provided valuable information for studying
heath outcomes that may initially present in different health care settings. The aim of this study was therefore, twofold: to
use linked primary and secondary care data to determine an optimum definition for estimating the incidence of first VTE in
and around pregnancy; and secondly to conduct a systematic literature review of studies on perinatal VTE incidence with
the purpose of comparing our estimates.
Methods: We used primary care data from the Clinical Practice Research Datalink (CPRD), which incorporates linkages to
secondary care contained within Hospital Episode Statistics (HES) between 1997 and 2010 to estimate the incidence rate of
VTE in the antepartum and postpartum period. We systematically searched the literature on the incidence of VTE during
antepartum and postpartum periods and performed a meta-analysis to provide comparison.
Findings: Using combined CPRD and HES data and a restrictive VTE definition, the absolute rate during the antepartum
period and first six weeks postpartum (early postpartum) were 99 (95%CI 85–116) and 468 (95%CI 391–561) per 100,000
person-years respectively. These were comparable to the pooled estimates from our meta-analysis (using studies after 2005)
during the antepartum period (118/100,000 person-years) and early postpartum (424/100,000 person-years). When we used
only secondary care data to identify VTE events, incidence was lower during the early postpartum period (308/100,000
person-years), whereas relying only on primary care data lead to lower incidence during the time around delivery, but
higher rates during the postpartum period (558/100,000 person-years).
Conclusion: Using combined CPRD and HES data gives estimates of the risk of VTE in and around pregnancy that are
comparable to the existing literature. It also provides more accurate estimation of the date of VTE diagnosis which will allow
risk stratification during specific pregnancy and postpartum periods.
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Introduction
Venous thromboembolism (VTE) is a serious complication of
pregnancy, however due to the low incidence of pregnancy related
VTEs and uncertainties over risk factors, prospective studies are
unlikely to be done because of prohibitive costs. Therefore, to
study its occurrence and risk factors, studies using routine data
have been used as they provide sufficient power and population
coverage to give robust and generalisable estimates [1,2]. The
recent linkage of electronic primary data in the Clinical Practice
Research Datalink (CPRD) with the secondary care English
Hospital Episode Statistics database (HES) may be useful in
providing valuable information on maternal risk factors for VTE
including hospitalisation, life style related factors and co-morbid-
ities. However, there have been no studies done using these linked
data to quantify the incidence of VTE in and around pregnancy.
Furthermore no studies have assessed the disparities between the
results from secondary and primary care data in a standalone
fashion versus when used together. Additionally, defining VTE
may be a concern as currently there have been no studies done to
validate VTE in linked primary and secondary data. Whilst VTE
has been previously validated in primary care data in non-
pregnant women with a positive predictive value (PPV) of 84% [3],
it is important to assess whether secondary care data add any
further information on VTE events around pregnancy especially
in the United Kingdom (UK) where almost all women deliver in
hospital. For instance, the previous validation study does not give
an indication of the negative predictive value and we cannot
ignore the potential for the incidence of VTE recorded in primary
care to be underestimated if certain VTE cases are solely recorded
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in secondary care. Further validation is also required to assess
potential false positive diagnoses in the peripartum period.
One way of assessing clinical information captured on VTE
during antepartum and postpartum periods is to compare
estimates of incidence to previous studies of VTE incidence.
However to-date, there has not been any formal data synthesis of
these previous studies nor an attempt at providing pooled
estimates of the incidence of VTE during the antepartum and
postpartum period. The aim of this study was therefore, twofold:
to use linked primary and secondary care data to determine an
optimum definition for estimating the incidence of first VTE in
and around pregnancy; and secondly to conduct a systematic
literature review of studies on perinatal VTE incidence with the
purpose of comparison to our estimates.
Methods
Databases and study population
Hospital Episode Statistics (HES). The Hospital episode
statistics dataset (HES) [4] contains details of all hospital
admissions to National Health Service (NHS) hospitals in England.
It contains demographic data along with information on discharge
diagnoses and procedures which are coded using International
Classification of Diseases (ICD) version 10 and Operation and
Procedure Coding Supplement (OPCS) version 4 respectively. All
diagnoses within the hospitalisation period (i.e. time they are
admitted until the time they are discharged from hospital) are
recorded within episodes (time period during which a patient is
under a particular consultant). We also used HES maternity data
and contains data on births across England and is the primary
source of maternity statistics in England which have been
validated [5].
Clinical Practice Research Datalink. The Clinical Practice
Research Datalink (CPRD) [6] is a computerized primary health
care database containing demographic, medical, prescription and
lifestyle related information from anonymised patient records
across the UK. The data are subjected to quality checks and only
the data which is of high quality is used for research. The GPRD
has been extensively validated for a wide range of chronic
diagnoses and consistently found to be accurate [7,8].
Linkage. The anonymised patient identifiers from CPRD
and HES have been linked by a trusted third party using NHS
number, date of birth and gender [9]. As HES only covers English
hospitals, practices from Northern Island, Wales and Scotland
were excluded. The primary care CPRD does not use a set
sampling approach to for its linkage with secondary care HES
data. It is based on practices that have consented to be linked to
HES in CPRD. However all patients within a consented practice
are included. Additionally our comparison of CPRD-HES linked
data to Office for National Statistics (ONS) data showing the age
distribution of the UK population has demonstrated similarities
[10]. For this study, we used 51% of the CPRD practices that had
linked HES data for their registered patients. We identified women
of reproductive age (15–44 years old) between 1997 and 2010
registered within the CPRD-HES linked practices as this was the
time for which HES linked data were available.
Defining venous thromboembolism
VTE diagnosis codes (including pulmonary embolism (PE) or
deep vein thrombosis (DVT)) were extracted from women’s
primary care data using medical Read codes. From HES, all
women with an ICD-10 code of venous thromboembolism
including pulmonary embolism (I26.0, I26.9), deep vein throm-
bosis (I80.1–I80.9) and portal vein thrombosis (I82.0–I82.9) were
extracted. ICD-10 codes of VTE specifically related to pregnancy
or postpartum (O22.2, O22.3, O87.1, O87.0, O08.2 and O88.2)
were also extracted. Information from either or both primary and
secondary care data sources was used to define a VTE event and
the first VTE diagnosis recorded in either data source was
considered as the incident date. We assessed only the first recorded
VTE during the study period and all subsequent VTEs were
excluded. We then developed the following three VTE definitions;
Definition A. Our most stringent definition included only
VTE diagnoses supported by prescription or evidence of
anticoagulant therapy (with either warfarin or unfractionated
heparin or low molecular weight heparin) within 90 days of the
event or death within 30 days of the event. Given the restricted use
of oral anticoagulants (e.g. warfarin) during the antepartum period
due to its teratogenicity, the majority of cases during the
antepartum period were confirmed based on heparin prescrip-
tions.
Definition B. This consisted cases where signs or symptoms
of DVT (e.g. leg pain, calf pain), PE (e.g. chest pain, shortness of
breath) or diagnostic tests for VTE (e.g. d-dimer, Ventilation-
Perfusion (VQ) scan, Computed Tomography (CT)-scan, venog-
raphy) had been recorded between 15 days before and 15 days
after a first recorded diagnosis of VTE, but there was no evidence
of anticoagulant therapy. Cases were also included if they had
VTE diagnoses in both primary and secondary care up to 60 days
apart, a cut-off based on the initial examination of the recording of
VTE in both datasets and prior work we and others have
published on identifying acute medical events in linked data
[11,12].
Definition C. This included all other diagnoses of VTE that
did not fit the criteria for VTE definitions A or B. Specifically, all
VTE diagnoses with no accompanying anticoagulant prescription,
medical code indicating anticoagulant therapy, death, signs or
symptoms of VTE, diagnostic tests for VTE. These cases were
only recorded in one data source (HES or CPRD).
Defining pregnancy and associated time periods
Information on birth outcome (including live birth and stillbirth)
was identified using the mother’s delivery records in HES
maternity data. For each pregnancy resulting in live or stillbirth,
the date of delivery was extracted from the OPCS version 4 codes
for delivery (e.g. emergency caesarean section, spontaneous
vaginal delivery). The date of conception was defined by
subtracting the length of gestation from the date of delivery. For
those with no information on length of gestation (33%), 40 weeks
was assigned. This corresponds to that of the majority of pregnant
women in the National Health Service’s (NHS) maternity statistics
for England [13]. Women’s follow-up time between age 15–44
years was divided into time associated with pregnancy (defined
from the date of any conceptions she had during follow-up until 12
weeks postpartum) and ‘‘non-pregnant periods’’ (all other available
follow-up time, which included all time for women who were
never pregnant during the study period as previously described
[14]). If the VTE event was recorded during the same hospital
admission as the women’s delivery (which accounted for 11% of all
VTE events), there was thus potential for misclassifying the timing
in relation to delivery. As 91% of deliveries occurred on the day
women were admitted to hospital for delivery or on the day after
and the median duration of hospital stay for delivery was only 2
days, the time associated with pregnancy was divided into the
antepartum period (trimesters from the date of conception until 2
days before the date of delivery), time around delivery (1 day
before until 2 days after delivery) and the postpartum period which
was defined from 3 days after delivery until 12 weeks postpartum.
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The postpartum period was subdivided into individual weeks and
also into early (first six weeks) and late (second six weeks)
postpartum) period.
Statistical analyses
Cohort analysis in linked data. The absolute rates (AR) of
VTE per 100,000 person-years and 95% Confidence Interval (CI)
were calculated for the antepartum period, time around delivery,
postpartum period and non-pregnant periods using VTE defini-
tions A, B and C separately. This was done by dividing the total
number of VTE events by person-years of follow-up. We then
restricted the analysis to first VTEs identified only in primary care
data and then VTEs only in secondary care data to compare these
with the overall estimates using both sources.
Systematic review and meta-analysis of existing VTE
incidence studies. For the purpose of comparing our rates to
the existing literature, we systematically reviewed previous studies
that have estimated VTE incidence among pregnant women or
during the postpartum period. We searched MEDLINE and
Embase for studies published between January 1960 and January
2013, combining a similar search strategy to that used in our
previously published VTE systematic review [15] with an adapted
version of the Cochrane Pregnancy Group search strategy to
obtain pregnancy studies [16]. The strategy used for MEDLINE
and Embase is summarised in Table S1 and S2 respectively. We
included studies only if they had estimated the rate of VTE in
pregnant and postpartum women in a manner that allowed us to
extract the data for the purposes of meta-analysis. Studies’
abstracts were independently reviewed for selection by two
investigators (AAS and JW) with differences resolved by consensus.
For each study included in our meta-analysis, the natural
logarithm of the incidence rate of VTE per 100,000 person-years
was obtained along with the standard errors (1/!VTE events). For
studies reporting rates of VTE per 100,000 pregnancies we
converted this into person-years of antepartum time by multiply-
ing the number of pregnancies by 0.75. For the meta-analysis, we
only assessed the first six weeks after childbirth during the
postpartum (although this was only the early postpartum period in
our cohort study) as this was the definition of postpartum used in
the majority of the included publications. These were then pooled
separately for antepartum and postpartum periods assuming
random effects using the generic inverse variance method. This
method considers the inverse variance of the effect estimates i.e. 1/
(standard error)2 as the weight given to each study, so a study with
more VTE events was given greater weight than studies with fewer
VTE events. A pooled estimate was also calculated for the third
trimester of pregnancy.
Given that diagnosis modalities have improved over the years
allowing for better ascertainment of VTE diagnosis in addition to
the increasing prevalence of maternal risk factors for VTE (for
example obesity), we performed a subgroup analysis by stratifying
studies based on calendar year (before and after 2005). This cut-off
was based on the initial examination of the forest plot on the
incidence of VTE during pregnancy which showed a marked
difference in the rate of VTE after 2005. We also stratified our
analyses based on whether or not VTE cases were subjected to a
degree of validation/confirmation, which varied from study to
study, however, we accepted methods similar to our criteria. The
methods used to validate/confirm VTE ranged from using a
validated algorithm to confirm VTE diagnosis or a registry where
VTE cases were previously validated to only including cases where
VTE had been objectively confirmed by diagnostic tests. A
Table 1. Basic characteristics of study population.
Variables N (%)
Total women in study 1,117,691
Median follow-up (Inter quartile range) in years 3.2 (1.23–6.50)
Pregnancy outcome (total pregnancies N=248,953)
Live births 247,436 (99.3)
Stillbirths 1,517 (0.61)
Study follow-up time in person-years (total study period=4,821,334)
Not pregnant 4,613,196
Antepartum 156,541
Time around delivery 2,381
Postpartum 49,216
doi:10.1371/journal.pone.0070310.t001
Table 2. Percentages of VTE cases in the study population
according to our three definitions.
Cases of first VTE N=3,507 n (%)
VTE definition A1 Total 1,805 (51.0)
Diagnosis of VTE in HES and CPRD 925 (51.2)*
Diagnosis in HES only 168 (9.4)*
Diagnosis in CPRD only 712 (39.4)*
VTE definition B2 Total 728 (20.6)
Diagnosis of VTE in HES and CPRD 161 (22.1)*
Diagnosis of VTE in HES only with supporting evidence 162 (22.2)*
Diagnosis of VTE in CPRD only with supporting evidence 405 (55.6)*
VTE definition C3 Total 974 (27.6)
Only HES with no supporting evidence 316 (32.4)*
Only CPRD with no supporting evidence 658 (67.5)*
1Recorded VTE with supporting anticoagulant prescription, or medical code
indicating anticoagulant therapy within 90 days of the event or death within 30
days of the event.
2Recorded VTE codes with supporting sign or symptom of VTE within 15 days
before or after the date of event.
3Recorded VTE with no evidence of signs and symptoms or anticoagulant
therapy.
*Percentages based on different denominators (in bold).
doi:10.1371/journal.pone.0070310.t002
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diagnosis of pulmonary embolism may have been confirmed by
pulmonary angiography, CT, Magnetic Resonance Imaging, VQ
scan, or pathological confirmation of thrombus. A diagnosis of
DVT may have been confirmed by Doppler ultrasound, duplex
ultrasonography, venography, or pathological confirmation of
thrombus.
The heterogeneity was assessed in terms of I.2 All data
management and statistical analysis was done using Stata MP11
(Stata Corp., College Station, Texas). This study was approved by
the Independent Scientific Advisory Committee (ISAC) that
governs use of the CPRD for research (reference num-
ber = 10_193R).
Results
Cohort analysis
Overall there were 1,117,691 women with follow-up data
between the ages of 15 and 44 years experiencing 248,953
pregnancies resulting in live or stillbirths (Table 1). The median
follow-up for each women was 3.2 years (IQR=1.2–6.5).
Defining first VTE using linked primary and secondary
care data. There were 3,507 cases of first VTE using both data
sources. Around 51% of the VTE cases were categorised under
VTE definition A of which 51% of diagnoses were recorded both
in primary and secondary care data (Table 2). Twenty percent of
all VTE cases were categorised under VTE definition B as they
had supporting evidence including signs or symptoms or a
diagnostic test documented 15 days before or after the date of
VTE diagnosis but did not meet our criteria for VTE definition A.
A total of 29% of all the VTEs were categorized as VTE definition
C, i.e. diagnoses with no supporting evidence, the majority of
which were in primary care data. When only using the primary
care data to identify first VTE cases, a total of 2,923 cases were
identified of which 58%, 19% and 23% where categorised under
VTE definition A, B and C respectively (data not shown). Similarly
1,946 potential VTE cases were identified when only using
secondary care data to identify first VTE of which 64%, 18% and
18% were categorized as VTE definition A, B and C respectively
(data not shown).
Timing of VTE diagnosis (for cases diagnosed both in
primary and secondary care). Of the total 1,086 VTE cases
documented in both primary and secondary care, 35% (n= 377)
Table 3. Rate of VTE per 100,000 person-years using different definitions of VTE in and around pregnancy (for pregnancies
resulting in live or stillbirths).
Time period VTE definition A
1, B2 or C3 VTE definition A1 or B2 VTE definition A1
n Rate* (95%CI) n Rate* (95%CI) n Rate* (95%CI)
Not pregnant 2,817 61 (58–63) 2040 44 (42–46) 1480 32 (30–33)
Antepartum 377 240 (217–266) 268 171 (151–192) 156 99 (85–116)
Trimester 1 47 95 (71–127) 41 83 (61–113) 23 46 (31–70)
Trimester 2 76 148 (118–186) 49 95 (74–126) 30 58 (41–83)
Trimester 3 254 450 (398–509) 178 315 (272–365) 103 182 (150–221)
Around delivery 76 3192 (423–546) 38 1596 (1161–2193) 34 1428 (1020–1998)
Postpartum 237 481 (423–546) 187 379 (329–438) 135 274 (231–324)
Early postpartum 200 801 (695–920) 157 629 (537–735) 177 468 (391–561)
Late postpartum 37 151 (109–208) 30 122 (95–175) 18 73 (46–116)
*Rate per 100,000 person-years.
**With women recorded as having a VTE event if they had a diagnosis in either database.
1Recorded VTE with supporting anticoagulant prescription, or medical code indicating anticoagulant therapy within 90 days of the event or death within 30 days of the
event.
2Recorded VTE codes with supporting sign or symptom of VTE within 15 days before or after the date of event.
3Recorded VTE with no evidence of signs and symptoms or anticoagulant therapy.
doi:10.1371/journal.pone.0070310.t003
Table 4. Incidence rate of VTE per 100,000 person-years in
and around pregnancy (for pregnancies resulting in live or
stillbirths) by data source.
Time period VTE definition A
1
n Rate* (95% CI)
Using only primary care data to identify first VTE events
Not pregnant 1387 30 (28–31)
Antepartum 126 80 (67–95)
Trimester 1 22 44 (29–68)
Trimester 2 31 60 (42–86)
Trimester 3 73 129 (102–162)
Around delivery 11 461 (255–833)
Postpartum 160 324 (278–379)
Early postpartum 138 552 (467–652)
Late postpartum 22 898 (591–136)
Using only secondary care data to identify first VTE events
Not pregnant 985 21 (19–22)
Antepartum 123 78 (65–93)
Trimester 1 18 36 (23–58)
Trimester 2 25 48 (32–72)
Trimester 3 80 141 (113–176)
Around delivery 43 1799 (1334–2426)
Postpartum 89 180 (146–221)
Early postpartum 76 303 (242–279)
Late postpartum 13 52 (30–91)
*Rate per 100,000 person-years.
doi:10.1371/journal.pone.0070310.t004
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had the same date of diagnosis for VTE in both datasets. Of the
total cases with a different date of diagnosis, 82% (n= 581) were
first diagnosed in HES with a median delay of 7 days (IQR=3–13)
until it was recorded in patients’ primary care records. For VTE
cases first diagnosed in primary care (number of cases = 128) there
was a median of 4 days difference (IQR=1–18) in the recording
between primary and secondary care date of VTE. This was
broadly the same in the antepartum period, postpartum period
and non-pregnant period.
Incidence of VTE in and around pregnancy. The rate of
any VTE (VTE definition A, B or C) during the time not
associated with pregnancy using both primary and secondary care
data was 61 per 100,000 person-years (Table 3). This rate
decreased by half when restricting to VTE definition A (32 per
100,000 person-years). When relying solely on primary care
recording of first VTE, the rate using VTE definition A during
antepartum, around delivery and postpartum periods was
calculated to be 80, 461 and 324 per 100,000 person-years
respectively (Table 4). Relying solely on secondary care data for
the recording of first VTE, the calculated VTE rate during the
time around delivery and postpartum was calculated to be 1799
and 180 per 100,000 person-years respectively.
During the early postpartum period, the observed rate of VTE
using both primary and secondary care data, peaked around the
time of delivery and the first week of postpartum period (AR=991
per 100,000 person years) after which the rates showed a graded
decline throughout the remaining postpartum period (Figure 1).
Compared to rates from the combined data sources, secondary
care data showed a similar rate around delivery but much lower
rates postpartum that decreased more rapidly following delivery.
In contrast, primary care data showed lower rates around delivery
but higher postpartum rates that remained consistently high until 4
weeks postpartum.
Systematic review and meta-analysis of perinatal VTE
incidence studies
We identified 1,831 articles of which 34 had their full-texts
reviewed and 21 were eventually included (Figure 2). The
characteristics of the included studies are presented in Table 5.
The incidence rate of VTE during the antepartum period from
previous studies ranged from 37 per 100,000 person-years in the
UK to 144 per 100,000 person-years in the U.S.A (data not
shown). The pooled incidence rate of VTE during the antepartum
period was 76 per 100,000 person-years (95% CI 65–90;
heterogeneity I2 = 97.6%). When restricting to studies where
VTE cases were validated/confirmed (14 studies) we found a
higher incidence of VTE after 2005 (AR=118 per 100,000
person-years I2 = 40%) compared to the rate before 2005 (AR=64
per 100,000; I2 = 0.0%) for the antepartum period. (Figure 3). The
pooled absolute rate of VTE during the third trimester of
pregnancy post 2005 (based on 389 VTE events; data not shown)
was calculated to be 142 per 100,000 person-years (95% CI 93–
158; I2 = 70%) when a similar restriction was applied. Similarly the
pooled absolute rate of VTE during the first six weeks postpartum
(post 2005) was calculated to be 424 per 100,000 person-years
(95%CI 238–755; I2 = 96%; Figure 4).
Comparison of meta-analysis estimates to the cohort
analysis
The estimates from the meta-analysis post-2005 are than lower
those generated using the inclusive VTE definition (VTE
definition A, B or C and VTE definition A or B). However using
only cases categorised under VTE definition A (those confirmed
based on prescriptions or death), the incidence rate of 99, 182 and
468 during the antepartum period, third trimester of antepartum
and early postpartum period (first six weeks after birth) from our
cohort analysis are in concordance with the pooled estimates from
recent studies (118, 142 and 424 respectively).
Figure 1. Rate of VTE in and around pregnancy and and non-pregnant periods using only VTE definition A.
doi:10.1371/journal.pone.0070310.g001
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Discussion
Main findings
In this study, we have shown that a highly specific definition of
VTE (VTE definition A) using data from both primary and
secondary care health care settings is required to accurately
estimate the incidence of VTE in and around pregnancy. The
estimates we have derived are comparable with the pooled
incidence rates for antepartum and early postpartum periods from
the existing literature. With the use of linked primary and
secondary care data we were able to get a far more accurate date
of diagnosis for VTE which resulted in more precise estimates of
rates close to delivery. Whilst the VTE rate can be accurately
estimated in the separate data sources in some circumstance (e.g.
trimesters of antepartum), when relying solely on primary care
data we found that the rate of VTE was much lower during the
time around delivery but higher during the postpartum period
compared to solely using secondary care data. This difference is
likely because of a delay in hospitalised events being recorded in
primary care. However when solely relying on secondary care data
the rate of VTE was much lower during the postpartum and non-
pregnant periods. We believe the best method for defining and
quantifying the incidence of VTE in and around pregnancy is
therefore to use both primary and secondary care data and apply
our VTE definition A to identify cases, as it has previously been
validated [3] and is externally comparable to other pregnancy
studies.
Ascertainment of VTE events
In our study, we were able to analyse 1,117,689 women of
childbearing age and over 248,000 pregnancies to determine how
the incidence of VTE in and around pregnancy varies based on
the VTE definition and the dataset used; such analysis has not
been done before. Our VTE definition A mimics a previously
validated VTE definition in primary care CPRD [3] data in a non-
pregnant population with a reported positive predictive value of
84%. To this algorithm we added secondary care diagnosis data
Figure 2. PRISMA flow diagram for identification of VTE incidence studies during pregnancy, postpartum or both.
doi:10.1371/journal.pone.0070310.g002
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which has an overall accuracy of 91% [17]. One current drawback
of UK secondary care data is the lack of information on hospital
prescribed heparin and warfarin which may have lead to under
ascertainment of cases using VTE definition A. However, we
believe that the impact of this limitation should be minimal as
pregnant women with a VTE diagnosis are expected to be on
anticoagulation therapy throughout their pregnancies and this
therapy period extends up to three months for postpartum women
[18]. Therefore these prescriptions are likely to be captured in the
primary care data. We must acknowledge that 33% of pregnancies
had no information on the length on gestation. When we
conducted a sensitivity analysis, however, and calculated the rate
of VTE stratified by those with and without information on
gestational age this showed no difference in our estimates of VTE
within each trimester of pregnancy.
Date of VTE diagnosis
Another strength of linked data is the improvement in
estimation of the date of diagnosis of VTE. The majority (84%)
of the VTEs diagnosed in both primary and secondary care using
the linked data had the diagnosis made in secondary care data
first. Therefore if we were reliant on primary care data alone there
would be a concern with the delay in recording of VTE from
secondary to primary care. Our study demonstrated a median lag
of 7 days in the recording of VTE events from secondary to
primary care. This delay can restrict the ability to give precise
incidence estimates in narrow windows of time such as around
delivery and probably explains our low incidence rate during the
time around delivery and prolonged high risk during the early
weeks of postpartum when only relying on primary care data for
VTE diagnosis. One potential limitation of the secondary care
Figure 3. Rate of VTE per 100,000 person years during the antepartum period only including studies where some degree of case
validation/confirmation was used. The data were stratified by year.
doi:10.1371/journal.pone.0070310.g003
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Figure 4. Rate of VTE per 100,000 person years during the postpartum (first six week after childbirth) period only including studies
where some degree of case validation/confirmation was used. The data were stratified by year.
doi:10.1371/journal.pone.0070310.g004
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data is the reliance on episode start date as the date of VTE event.
This creates problems in separating out antepartum versus
postpartum VTE events around the time of delivery. An example
of this problem is that reported in a cohort study of women
delivering in hospital by Virkus et.al [19] who considered the date
of admission to hospital as the date of diagnosis for VTE. They
reported a high rate of VTE during the third trimester of the
antepartum compared to previous studies in the meta-analysis post
2005. This may be explained by some postpartum VTE events
occurring during the maternal admission having been classified as
antepartum. A similar, yet not acknowledged, problem may be the
case for other studies utilizing hospital discharge data [20,21]. In
our study, HES provides a better option in terms of date of
episodes for each diagnosis within each hospital period. We think
this rather than the date of hospital admission or discharge will
more accurately estimate the true VTE diagnosis date (although
not necessarily the actual biological onset of the VTE). Further-
more the division of pregnancy periods as antepartum, around
delivery, and postpartum adequately addresses the concern of mis-
classification of VTE events around childbirth.
Table 5. Characteristics of the studies included by year of publication.
Author (Year of
publication) Country
Study
period Study design and methodology Measures taken to confirm VTE
Sultan [14]
(2012)
United
Kingdom
1987–
2004
Population based retrospective cohort. Cases were
identified using primary care data which were validated
VTE cases were confirmed based on anticoagulant therapy
Vikrus [19]
(2011)
Denmark 1995–
2005
Population based retrospective cohort. Cases were
identified from national registry using ICD-10 codes.
Registry was validated for VTE during pregnancy with PPV
of more than 80%
O’Cornnor [29]
(2011)
United
States
2003–
2008
Cross sectional study. Cases were identified
from a single hospital.
VTE cases were objectively confirmed based on
diagnostics tests1
Liu [30] (2009) Canada 1991–
2006
Cross sectional study. Cases were identified
using hospital discharge database using ICD-10 codes.
No measures taken to confirm VTE
Lyall [31] (2008) United
Kingdom
1999–
2007
Cross sectional study. Cases were identified
from a single unit
VTE cases were objectively confirmed based on
diagnostics tests1
Jacobsen [25]
(2008)
Norway 1990–
2003
Cross sectional study. Cases were identified
from patient and birth register.
VTE cases were validated for the subset of the data
Lindqvist [32]
(2008)
Sweden 1990–
2005
Cross sectional study. Cases were identified
from a single hospital.
VTE cases were objectively confirmed based on
diagnostics tests1
Sharma [27]
(2008)
Australia 1999–
2006
Cross sectional study. Cases were identified
from a single hospital.
VTE cases were objectively confirmed based on
diagnostics tests1
Larsen [33]
(2007)
Denmark 1980–
2001
Cross sectional study. Cases were identified
from a single county.
VTE cases were objectively confirmed based on
diagnostics tests1
James [20]
(2006)
United
States
2000–
2001
Cross-sectional study. Cases were identified
from national inpatient sample which covers
around 100 hospitals using ICD-10 codes.
VTE cases were objectively confirmed1. Included some
probable and possible VTEs
Heit [34] (2005) United
States
1966–
1995
Population based cohort. Potentially fertile
women were prospectively followed in a single county.
VTE cases were objectively confirmed1. Included some
probable and possible VTEs
Haggaz [35]
(2003)
Sudan 1999–
2000
Cross sectional study. Cases were identified
from a single hospital.
VTE cases were objectively confirmed based on
diagnostics tests1
Anderson [36]
(2003)
Denmark 1984–
1994
Cross sectional study. Cases were identified
using inpatient registry.
VTE cases were objectively confirmed based on
diagnostics tests1
Soomro [37]
(2002)
Saudi
Arabia
1986–
1998
Cross sectional study. Cases were identified
from a single hospital.
VTE cases were objectively confirmed based on
diagnostics tests1
Chan [24]
(2001)
Japan 1998–
2000
Cross sectional study. Cases were identified
from a single hospital.
VTE cases were objectively confirmed based on
diagnostics tests1
Ros [1] (2001) Sweden 1987–
1995
Population based retrospective cohort. Cases
were identified using inpatient registry using ICD-9 codes
No measures taken to confirm VTE
Simpon [21]
(2001)
United
Kingdom
1988–
1997
Cross sectional study in which cases were
identified using ICD codes from hospital database
No measures taken to confirm VTE
Gherman [26]
(1999)
United
States
1978–
1996
Cross sectional study. Cases were identified
from a single hospital.
VTE cases were objectively confirmed based on
diagnostics tests1
Lindqvist [38]
(1999)
Sweden 1990–
1993
Cross sectional study. Cases were identified
from Swedish birth and patient registry
No measures taken to confirm VTE
McColl [39]
(1997)
United
Kingdom
1985–
1996
Cross sectional study. Cases were identified
using national health service data.
VTE cases were objectively confirmed based on
diagnostics tests1
James [40]
(1996)
United
States
1989–
1994
Cross sectional study where cases were identified
from medical records at a single hospital.
No measures taken to confirm VTE
1A diagnosis of pulmonary embolism may be confirmed by pulmonary angiography, CT, MRI, ventilation-perfusion scan, pathological confirmation of thrombus etc.
whereas the diagnosis of DVT may be confirmed by Doppler ultrasound, duplex ultrasconography, venography, pathological confirmation of thrombus etc. each of
which may vary from study to study.
doi:10.1371/journal.pone.0070310.t005
Venous Thromboembolism in and around Pregnancy
PLOS ONE | www.plosone.org 9 July 2013 | Volume 8 | Issue 7 | e70310
Meta-analysis
Our meta-analyses showed high levels of heterogeneity occur-
ring among the individual studies for both antepartum and
postpartum pooled estimates. In descriptive epidemiological
studies where a statistic is estimated among a single group (such
as pregnant women in this review), the potential for heterogeneity
is far greater than for analytic or comparative studies (i.e., when
two groups are compared to calculate a measure of effect such as
an odds or risk ratio). This is because incidence rates are very
sensitive to the choice of study population, outcome definition and
dataset used meaning at least some heterogeneity will be
inevitable; other published meta-analyses of this type also report
very high levels of heterogeneity [15,22,23]. The heterogeneity in
our data during the antepartum period was partially explained by
calendar year and whether VTE cases were subjected to a certain
degree of validation/confirmation or not. For instance, when we
restricted our analysis only to studies where VTE cases were
validated/confirmed and stratified them by calendar year, our I2
value was less than 50%. For the postpartum, incidence rates
during the first six weeks post-delivery were largely inconsistent
even after restricting to studies with validated/confirmed VTE and
stratifying the estimates by calendar year. This wide variation in
the reported rates can probably be explained by the various
countries’ health care systems and their thromboprophylaxis
practices after childbirth. The UK Royal College of Obstetricians
and Gynaecologists recommendation on VTE risk assessment and
thromboprophylaxis post-caesarean section dates back to 1993,
which may have been adapted by different countries at different
points in time. For instance a study from China [24] reported the
rate of VTE to be 1228 per 100,000 person-years where there was
no concept of thromboprophylaxis prior to the year 2000 versus
studies from Norway [25] and UK [14] with lower reported rates
(AR around 400 per 100,000 person-years). This is something we
were not able to account of in our meta-analysis for postpartum
VTE. Most of the previous literature on this subject has relied on
secondary care data which will inevitably miss many non-fatal
VTE events diagnosed and managed exclusively in primary care,
particularly during the postpartum period [1,19,26,27].
Although we did no external validation of our VTE definitions
among women included in our cohort study, based on our most
inclusive definition (i.e. including events categorised under VTE
definition A, B or C) our calculated rates of VTE during
antepartum and postpartum periods were considerably higher
than the pooled incidence rate of previous studies. This suggests
the inclusion of many false positive events, limiting the validity of
such an inclusive VTE definition. The same issue occurred,
although to a lesser extent, when including VTE events classified
under VTE definition A or B where we included cases with clinical
signs and symptoms of VTE or evidence of diagnostic tests in
addition to anticoagulant therapy. This may be due to the fact that
leg swelling and calf pain are common in the third trimester of
pregnancy in women without DVT which can lead to potential
misclassification. Additionally, D-dimer levels increase [28] in
pregnancy, with gestational hypertension, and in preterm labour
leading to false positive events which may add to that misclassi-
fication. In contrast the absolute rates of VTE using VTE
definition A for antepartum and postpartum periods of 99 and 468
per 100,000 person-years respectively are broadly in concordance
with pooled estimates from previous studies using similar
methodology where VTE cases were validated/confirmed.
Conclusions
Our results have important implications for the way in which
VTE is studied in pregnancy using routinely available electronic
health care records, data which are crucial for assessing outcomes
that are severe and rare and thus rely on evidence from large
population-based sources. Firstly, we have quantified the incidence
of VTE in and around pregnancy using a variety of VTE
definitions. This demonstrated that the absolute rate of VTE
greatly varies based on the VTE definition used, with our VTE
definition A providing the most comparable estimates of the
absolute rates to previous work. We have also demonstrated that
there are some important limitations in using solely primary care
or secondary care data in terms of the date and ascertainment of
VTE diagnosis which need to be considered when interpreting
studies that do this. We have shown in our study that using both
primary and secondary care data not only provide better
estimation of the date of VTE diagnosis, but also enable
researchers to comprehensively identify VTE cases diagnosed
and recorded both in primary or secondary care. Furthermore, the
use of both primary and secondary care data combined may
provide better ascertainment of maternal risk factors for VTE,
information on hospitalization, primary care prescriptions, infor-
mation on life style related factors and co-morbidities. This vital
information could be used to better understand the occurrence
and risk factors of VTE in and around pregnancy for future
research
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